Has Sahar Rabiei-Samani received payments from drug or device companies?

Yes. Drug and device makers reported $2,891 in general payments to Sahar Rabiei-Samani across 25 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sahar Rabiei-Samani did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sahar Rabiei-Samani come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sahar Rabiei-Samani

Pulmonary Disease · Ridgewood, NJNPI 1275995284

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 33.3% of the total. 2025 is the largest year on record at $1,623, more than ten times the $53 reported in 2019.

$2,891in general payments, 2019–2025

Across 25 payments — averaging $115.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$963
Olympus Corporation Of The Americas$279
United Therapeutics Corporation$257
AstraZeneca$246
La Jolla Pharmaceutical Company$214
Sanofi$203
plus $729 from 5 others

What the payments were for

Travel & lodging$1,04336%
Food & beverage$1,70559%
Education$1445%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	6	$963
Olympus Corporation Of The Americas	2	$279
United Therapeutics Corporation	3	$257
AstraZeneca	2	$246
La Jolla Pharmaceutical Company	2	$214
Sanofi	2	$203
Harmony Biosciences LLC	2	$185
Pulmonx Corporation	1	$177
Merck	2	$154
Avadel CNS Pharmaceuticals, LLC	2	$133
Sanofi-aventis U.S. LLC	1	$79

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,891 in reported general payments places this provider in the 55th percentile of 472 pulmonary disease providers in New Jersey.

See all pulmonary disease providers in New Jersey →

Medicare billing

Part B allowed, 2024

$123,854

Medicare patients

413

Services billed

955

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	22	$15,158
Incruse ElliptaUmeclidinium Bromide	20	$6,689
Breo ElliptaFluticasone/Vilanterol	14	$6,683
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	14	$6,585
Wixela InhubFluticasone Propion/Salmeterol	17	$2,268
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	26	$1,785
Albuterol Sulfate HfaAlbuterol Sulfate	33	$906
Fluticasone Propionate	16	$291
Prednisone	48	$177
Montelukast Sodium	22	$81
Azithromycin	19	$58

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Ridgewood

Joseph HoffmanPark Ridge$1.1M
Reynold PanettieriNew Brunswick$1M
Robert SussmanSummit$551K
Manuel CunananMillville$489K
Emanuele SantomauroHackensack$420K
Richard MillerNewark$328K
Jason ShatkinParamus$282K
Anthony RickettiTrenton$225K
Jeffrey MiskoffManasquan$176K
Peter SacconeLinwood$149K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →